Injectable GHK-Cu is classified by the FDA as a Category 2 substance, which restricts its compounding at 503A pharmacies, and it is not FDA-approved for any indication
Promotes Cardiovascular Healing Animal studies show BPC-157 can reduce vascular leakage, protect blood vessels, and enhance heart function during stress or trauma
It has shown superior synaptogenic activity in vitro and in vivo, with 7x the potency of BDNF in some models
Musculoskeletal support Research has explored protective and regenerative effects on muscle, bone, and cartilage under injury conditions
Study designs are shown in Fig
However, it requires a prescription and may carry side effects, including an increased risk of blood clots and breast cancer